Evidence map›Paper›PMID 25955155›Full record

ArticlePloS one2015

pGlcNAc Nanofiber Treatment of Cutaneous Wounds Stimulate Increased Tensile Strength and Reduced Scarring via Activation of Akt1.

Haley Buff Lindner, Lloyd McPherson Felmly, Marina Demcheva, Arun Seth, Russell Norris, Amy D Bradshaw, John Vournakis, Robin C Muise-Helmericks

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Testing a novel nanofibre scaffold for utility in bone tissue regeneration.Journal of tissue engineering and regenerative medicine · 2018
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Haley Buff LindnerDepartment Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, 29425, United States of America.
Lloyd McPherson FelmlyDepartment Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, 29425, United States of America.
Marina DemchevaMarine Polymer Technologies, Inc., Danvers, MA, 01923, United States of America.
Arun SethSunnybrook Research Institute, University of Toronto, Toronto, Ontario, M5G 1G6, Canada.
Russell NorrisDepartment Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, 29425, United States of America.
Amy D BradshawDepartment of Medicine, Medical University of South Carolina, Charleston, SC, 29425, United States of America.
John VournakisMarine Polymer Technologies, Inc., Danvers, MA, 01923, United States of America.
Robin C Muise-HelmericksDepartment Regenerative Medicine and Cell Biology, Medical University of South Carolina, Charleston, SC, 29425, United States of America.
Medical University of South Carolina · USMarine Polymer Technologies (United States) · USSunnybrook Health Science Centre · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of cutaneous wounds with poly-N-acetyl-glucosamine containing nanofibers (pGlcNAc), a novel polysaccharide material derived from a marine diatom, results in increased wound closure, antibacterial activities and innate immune responses. We have shown that Akt1 plays a central role in the regulation of these activities. Here, we show that pGlcNAc treatment of cutaneous wounds results in a smaller scar that has increased tensile strength and elasticity. pGlcNAc treated wounds exhibit decreased collagen content, increased collagen organization and decreased myofibroblast content. A fibrin gel assay was used to assess the regulation of fibroblast alignment in vitro. In this assay, fibrin lattice is formed with two pins that provide focal points upon which the gel can exert force as the cells align from pole to pole. pGlcNAc stimulation of embedded fibroblasts results in cellular alignment as compared to untreated controls, by a process that is Akt1 dependent. We show that Akt1 is required in vivo for the pGlcNAc-induced increased tensile strength and elasticity. Taken together, our findings suggest that pGlcNAc nanofibers stimulate an Akt1 dependent pathway that results in the proper alignment of fibroblasts, decreased scarring, and increased tensile strength during cutaneous wound healing.

Indexed as

AcetylglucosamineAnimalsAnti-Bacterial AgentsCicatrixGene Expression RegulationMiceNanofibersProto-Oncogene Proteins c-aktSignal TransductionSkinTensile StrengthWound HealingAcetylglucosamineAkt1 protein, mouseAnti-Bacterial Agentspoly-N-acetyl glucosamineProto-Oncogene Proteins c-akt

Identifiers

PMID25955155
PMCPMC4425470
OpenAlexW276143282

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.